Survivin multifaceted activity in head and neck carcinoma: Current evidence and future therapeutic challenges

References

• Lippert BH, Knauer SK, Fetz V, Mann W, Stauber RH. Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential. Int J Cancer 2007; 121: 1169–74
   PubMed Web of Science ®Google Scholar
• Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008; 14: 5000–5
   PubMed Web of Science ®Google Scholar
• Marioni G, Bedogni A, Giacomelli L, Ferraro SM, Bertolin A, Facco E, et al. Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas. Acta Otolaryngol 2005; 125: 1218–23
   PubMed Web of Science ®Google Scholar
• Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917–21
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Ngan CY, Monden M. Cancer cells survive with survivin. Cancer Sci 2008; 99: 1709–14
   PubMed Web of Science ®Google Scholar
• Marioni G, Pillon M, Bertolin A, Staffieri A, Marino F. The role of survivin expression in the differential diagnosis of laryngeal (glottic) verrucous squamous cell carcinoma. Eur J Surg Oncol 2007; 33: 229–33
   PubMed Web of Science ®Google Scholar
• Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581–9
   PubMed Web of Science ®Google Scholar
• Marioni G, Marino F, Bertolin A, Giacomelli L, Marchese-Ragona R, Savastano M, et al. Expression of the apoptosis inhibitor protein survivin in primary, laryngeal carcinoma and cervical lymph node metastases. Anticancer Res 2006; 26: 3813–18
   PubMed Web of Science ®Google Scholar
• Li F, Ling X. Survivin study: an update of “what is the next wave”?. J Cell Physiol 2006; 208: 476–86
   PubMed Web of Science ®Google Scholar
• Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE, et al. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ 2002; 9: 1334–42
   PubMed Web of Science ®Google Scholar
• Badran A, Yoshida A, Ishikawa K, Goi T, Yamaguchi A, Ueda T, et al. Identification of a novel splice variant of the human anti-apoptopsis gene survivin. Biochem Biophys Res Commun 2004; 314: 902–7
   PubMed Web of Science ®Google Scholar
• Caldas H, Honsey LE, Altura RA. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies. Mol Cancer 2005; 4: 1–9
   PubMed Web of Science ®Google Scholar
• Rodríguez JA, Span SW, Ferreira CG, Kruyt FA, Giaccone G. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Exp Cell Res 2002; 275: 44–53
   PubMed Web of Science ®Google Scholar
• Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, et al. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1999; 1: 461–6
   PubMed Web of Science ®Google Scholar
• Xia F, Altieri DC. Mitosis-independent survivin gene expression in vivo and regulation by p53. Cancer Res 2006; 66: 3392–5
   PubMedGoogle Scholar
• Du C, Fang M, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33–42
   PubMed Web of Science ®Google Scholar
• Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL, et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000; 10: 1319–28
   PubMed Web of Science ®Google Scholar
• De Maria S, Pannone G, Bufo P, Santoro A, Serpico R, Metafora S, et al. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol 2009; 135: 107–16
   PubMed Web of Science ®Google Scholar
• Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggio MA, et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer 2003; 89: 2244–8
   PubMed Web of Science ®Google Scholar
• Lo Muzio L, Staibano S, Pannone G, Mignogna MD, Mariggio A, Salvatore G, et al. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 2001; 70: 249–54
   PubMed Web of Science ®Google Scholar
• Kim M-J, Lim K-Y, Kim J-W, Nam I-W, Lee J-H, Myoung H. Stage and m-RNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma. Cancer Lett 2005; 224: 253–61
   PubMed Web of Science ®Google Scholar
• Engels K, Knauer SK, Metzler D, Simf C, Struschka O, Bier C, et al. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J Pathol 2007; 211: 532–40
   PubMed Web of Science ®Google Scholar
• Freier K, Pungs S, Sticht C, Flechtenmacher C, Lichter P, Joos S, et al. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy. Int J Cancer 2007; 120: 942–6
   PubMed Web of Science ®Google Scholar
• Weinman EC, Roche PC, Kasperbauer JL, Cha SS, Sargent DJ, Cheville J, et al. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma. Cancer 2003; 97: 2203–11
   PubMed Web of Science ®Google Scholar
• Preuss SF, Weinell A, Molitor M, Stenner M, Semrau R, Drebber U, et al. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. Br J Cancer 2008; 98: 627–32
   PubMed Web of Science ®Google Scholar
• Preuss SF, Weinell A, Molitor M, Semrau R, Stenner M, Drebber U, et al. Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma. Head Neck 2008; 30: 1318–24
   PubMed Web of Science ®Google Scholar
• Sharma H, Sen S, Mathur M, Bahadur S, Singh N. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic BCL-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck 2004; 26: 733–40
   PubMed Web of Science ®Google Scholar
• Pizem J, Cör A, Gale N. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 2004; 45: 180–6
   PubMed Web of Science ®Google Scholar
• Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 2002; 22: 2377–83
   PubMed Web of Science ®Google Scholar
• Zhao H, Ren J, Zhuo X, Ye H, Zou J, Liu S. Prognostic significance of survivin and CD44v6 in laryngeal surgical margins. J Cancer Res Clin Oncol 2008; 134: 1051–8
   PubMed Web of Science ®Google Scholar
• Farnebo L, Jerhammar F, Vainikka L, Grénman R, Norberg-Spaak L, Roberg K. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines. Oncology Rep 2008; 20: 453–61
   PubMed Web of Science ®Google Scholar
• Chen X, Luan X, Lei D, Ma X, Liu X, Liu J, et al. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells. ORL J Otorhinolaryngol Relat Spec 2008; 70: 168–75
   PubMedGoogle Scholar
• Bang CI, Paik SY, Sun DI, Joo YH, Kim MS. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line. Ann Otol Rhinol Laryngol 2008; 117: 781–5
   PubMed Web of Science ®Google Scholar
• Cheng B, Yang X, Han Z, An L, Liu S. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA. Auris Nasus Larynx 2008; 35: 95–101
   PubMed Web of Science ®Google Scholar
• Kojima H, Iida M, Yaguchi Y, Suzuki R, Hayashi N, Moriyama H, et al. Enhancement of cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene. Arch Otolaryngol Head Neck Surg 2006; 132: 682–5
   PubMedGoogle Scholar
• Jiang G, Li J, Zeng Z, Xian L. Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma. Cancer Biol Ther 2006; 5: 435–40
   PubMed Web of Science ®Google Scholar
• Sharma H, Sen S, Lo Muzio L, Mariggiò MA, Singh N. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. Cancer Biol Ther 2005; 4: 720–7
   PubMed Web of Science ®Google Scholar